Zhejiang Qianjiang Biochemical Co Ltd
Zhejiang Qianjiang Biochemical Co., Ltd., together with its subsidiaries, researches, develops, produces, sells, and services biopesticides in China and internationally. The company offers biopesticide products comprising plant growth regulators consisting of gibberellic acid and gibberellic acid A4+A7; insecticides, such as avermectin and emamectin benzoate; and fungicides, including jinggangmyc… Read more
Zhejiang Qianjiang Biochemical Co Ltd (600796) - Total Liabilities
Latest total liabilities as of September 2025: CN¥3.67 Billion CNY
Based on the latest financial reports, Zhejiang Qianjiang Biochemical Co Ltd (600796) has total liabilities worth CN¥3.67 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Qianjiang Biochemical Co Ltd - Total Liabilities Trend (1994–2024)
This chart illustrates how Zhejiang Qianjiang Biochemical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhejiang Qianjiang Biochemical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Qianjiang Biochemical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Summarecon Agung Tbk
JK:SMRA
|
Indonesia | Rp22.10 Trillion |
|
Cubic Sensor and Instrument Co Ltd
SHG:688665
|
China | CN¥543.68 Million |
|
Franklin Financial Services Corp
NASDAQ:FRAF
|
USA | $-166.34 Million |
|
India Glycols Limited
NSE:INDIAGLYCO
|
India | ₹37.64 Billion |
|
Abaxx Technologies Inc
OTCQX:ABXXF
|
USA | $41.24 Million |
|
Univanich Palm Oil Public Company Limited
BK:UVAN
|
Thailand | ฿746.51 Million |
|
Duni AB
ST:DUNI
|
Sweden | Skr4.02 Billion |
Liability Composition Analysis (1994–2024)
This chart breaks down Zhejiang Qianjiang Biochemical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Qianjiang Biochemical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Qianjiang Biochemical Co Ltd (1994–2024)
The table below shows the annual total liabilities of Zhejiang Qianjiang Biochemical Co Ltd from 1994 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.99 Billion | +18.36% |
| 2023-12-31 | CN¥3.37 Billion | +2.42% |
| 2022-12-31 | CN¥3.29 Billion | +3.41% |
| 2021-12-31 | CN¥3.19 Billion | +571.12% |
| 2020-12-31 | CN¥474.74 Million | +97.36% |
| 2019-12-31 | CN¥240.55 Million | -27.83% |
| 2018-12-31 | CN¥333.30 Million | -13.73% |
| 2017-12-31 | CN¥386.35 Million | -1.85% |
| 2016-12-31 | CN¥393.63 Million | -17.35% |
| 2015-12-31 | CN¥476.25 Million | -11.51% |
| 2014-12-31 | CN¥538.20 Million | -8.58% |
| 2013-12-31 | CN¥588.72 Million | -27.67% |
| 2012-12-31 | CN¥813.97 Million | +14.16% |
| 2011-12-31 | CN¥713.02 Million | +50.05% |
| 2010-12-31 | CN¥475.18 Million | +32.85% |
| 2009-12-31 | CN¥357.69 Million | -4.10% |
| 2008-12-31 | CN¥372.97 Million | -18.14% |
| 2007-12-31 | CN¥455.64 Million | +3.59% |
| 2006-12-31 | CN¥439.87 Million | +11.34% |
| 2005-12-31 | CN¥395.05 Million | +72.16% |
| 2004-12-31 | CN¥229.46 Million | +30.75% |
| 2003-12-31 | CN¥175.50 Million | +6.51% |
| 2002-12-31 | CN¥164.76 Million | -11.54% |
| 2001-12-31 | CN¥186.25 Million | +18.10% |
| 2000-12-31 | CN¥157.71 Million | +81.86% |
| 1999-12-31 | CN¥86.72 Million | +5.41% |
| 1998-12-31 | CN¥82.27 Million | +143.25% |
| 1997-12-31 | CN¥33.82 Million | -39.20% |
| 1996-12-31 | CN¥55.62 Million | +20.68% |
| 1995-12-31 | CN¥46.09 Million | +30.64% |
| 1994-12-31 | CN¥35.28 Million | -- |